Lung Cancer Risk Among Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap.

RATIONALE Chronic obstructive pulmonary disease (COPD) is a well-established independent risk factor for lung cancer, while the literature on the association between asthma and lung cancer is mixed. Whether Asthma COPD Overlap (ACO) is associated with lung cancer has not been studied. OBJECTIVES We aimed to compare lung cancer risk among patients with ACO vs. COPD and other conditions associated with airway obstruction. METHODS We studied 13,939 smokers from the National Lung Cancer Screening Trial who had baseline spirometry, and utilized spirometric indices and history of childhood asthma to categorize participants into 5 specific airway disease subgroups. We used Poisson regression to compare unadjusted and adjusted lung cancer risk. RESULTS The incidence rate of lung cancer per 1,000 person-years was: ACO, 13.2 (95% confidence interval [CI]: 8.1-21.5); COPD, 11.7 (95% CI: 10.5-13.1); asthmatic smokers, 1.8 (95% CI: 0.6-5.4); Global Initiative for Chronic Obstructive Lung Disease-Unclassified, 7.7 (95% CI: 6.4-9.2); and normal-spirometry smokers, 4.1 (95% CI: 3.5-4.8). ACO patients had increased adjusted risk of lung cancer compared to patients with asthma (incidence rate ratio [IRR]: 4.5, 95% CI: 1.3-15.8) and normal spirometry smokers (IRR: 2.3, 95% CI: 1.3-4.2) in models adjusting for other risk factors. Adjusted lung cancer incidence in patients with ACO and COPD were not found to be different (IRR: 1.2, 95% CI 0.7 - 2.1). CONCLUSIONS Risk of lung cancer among patients with ACO is similar to those with COPD and higher than other groups of smokers. These results provide further evidence that COPD, with or without a history of childhood asthma, is an independent risk factor for lung cancer.

[1]  P. Śliwiński,et al.  Asthma-COPD Overlap-A Discordance Between Patient Populations Defined by Different Diagnostic Criteria. , 2019, The journal of allergy and clinical immunology. In practice.

[2]  L. Lynd,et al.  Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study , 2019, European Respiratory Journal.

[3]  J. Utikal,et al.  Opposing roles of eosinophils in cancer , 2018, Cancer Immunology, Immunotherapy.

[4]  R. Hopkins,et al.  Chronic obstructive pulmonary disease (COPD) and lung cancer screening. , 2018, Translational lung cancer research.

[5]  I. Pavord,et al.  Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles , 2018, Journal of Allergy and Clinical Immunology.

[6]  Jun Liu,et al.  Asthma and the risk of lung cancer: a meta-analysis , 2017, Oncotarget.

[7]  A. Munitz,et al.  Emerging Roles for Eosinophils in the Tumor Microenvironment. , 2016, Trends in cancer.

[8]  R. Panettieri Neutrophilic and Pauci-immune Phenotypes in Severe Asthma. , 2016, Immunology and allergy clinics of North America.

[9]  I. Pavord,et al.  Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease , 2015, The Journal of allergy and clinical immunology.

[10]  A. Hofman,et al.  Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis , 2014, European Respiratory Journal.

[11]  Edwin J R van Beek,et al.  The clinical and genetic features of COPD-asthma overlap syndrome , 2014, European Respiratory Journal.

[12]  J. Siemiatycki,et al.  History of allergic diseases and lung cancer risk. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  T. Keistinen,et al.  High hospital burden in overlap syndrome of asthma and COPD , 2013, The clinical respiratory journal.

[14]  J. Soriano,et al.  Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. , 2013, Respiratory medicine.

[15]  E. Antón,et al.  Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). , 2013, Respiratory medicine.

[16]  H. Morgenstern,et al.  Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. , 2012, Carcinogenesis.

[17]  R. Hopkins,et al.  How the genetics of lung cancer may overlap with COPD , 2011, Respirology.

[18]  Joyce D. Schroeder,et al.  The clinical features of the overlap between COPD and asthma , 2011, Respiratory research.

[19]  Adam M. Gustafson,et al.  A chronic obstructive pulmonary disease related signature in squamous cell lung cancer. , 2011, Lung cancer.

[20]  T. Haahtela,et al.  Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[21]  Ian M. Adcock,et al.  Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights , 2011, Respiration.

[22]  D. Brenner,et al.  Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors , 2010, BMC Cancer.

[23]  P. Gibson,et al.  The overlap syndrome of asthma and COPD: what are its features and how important is it? , 2009, Thorax.

[24]  P. Barnes Immunology of asthma and chronic obstructive pulmonary disease , 2008, Nature Reviews Immunology.

[25]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[26]  E. Pukkala,et al.  Cancer incidence among 78,000 asthmatic patients. , 1993, International journal of epidemiology.

[27]  M. Sánchez-Borges,et al.  Preventive role of atopy in lung cancer. , 1986, Clinical immunology and immunopathology.

[28]  T. Byers,et al.  Allergy-related diseases and cancer: an inverse association. , 1985, American journal of epidemiology.

[29]  R. Medeiros,et al.  The role of inflammation in lung cancer. , 2014, Advances in experimental medicine and biology.